Identification of risk factors and development of a predictive model for chronic kidney disease in patients with obesity: a four-year cohort study

被引:0
作者
Zhang, Haixia [1 ,2 ]
Zhang, Yue [1 ,2 ]
Gao, Wenxing [1 ]
Mu, Yiming [2 ,3 ]
机构
[1] PLA Med Sch, Beijing, Peoples R China
[2] Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Endocrinol, Beijing, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, 28 Fuxing Rd, Beijing 100853, Peoples R China
关键词
Prediction model; Chronic kidney disease; Obesity; BODY-MASS INDEX; PREVALENCE; CHINA;
D O I
10.1186/s12944-024-02048-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objective The sneaky onset and dismal prognosis of chronic kidney disease (CKD) make it an important public health issue. Obesity-related kidney illness has garnered more attention in recent times. Establishing and validating a risk prediction model for chronic renal illness in overweight or obese adults was the goal of this investigation. Methods Data from the China Health and Retirement Longitudinal Study were used for analysis. The definition of CKD was reduced renal function (eGFR < 60 mL/min/1.73 m(2)), while overweight and obesity were characterized through a body mass index exceeding 24 kg/m(2). The dataset was divided into derivation and validation cohorts using a 7:3 ratio. With respect to the derivation cohort, we constructed a prediction model using LASSO analysis and multivariate logistic regression. The model's performance was evaluated using Hosmer-Lemeshow tests, calibration curves, decision curve analysis, and receiver operating characteristic (ROC) curves. The validation cohort's model was subjected to additional assessment. Results The study was based on survey data from 2011 to 2015 and comprised 3246 individuals who were overweight or obese, with 2274 being part of the derivation cohort and 972 being part of the validation cohort. The research constructed a prediction model that included age, sex, fasting blood glucose, glycated hemoglobin, triglyceride, hypertension, and BMI. The validation cohort's area under the ROC curve was 0.812 (95% CI = 0.763, 0.859) while the derivation cohort's was 0.789 (95% CI = 0.754, 0.831). Hosmer-Lemeshow tests were utilized to evaluate the model's accuracy in the validation and derivation cohorts (P = 0.681 and 0.547, respectively). The calibration curve showed a high level of consistency between the actual observations and the projected outcomes. According to decision curve analysis, the model offered significant net advantages. Conclusions The forecasting model established in this research has predictive value for CKD in patients with overweight or obesity. These findings could help doctors conduct early detection and intervention in clinical practice and further improve patient prognosis.
引用
收藏
页数:10
相关论文
共 32 条
  • [1] Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States
    Aggarwal, Rahul
    Vaduganathan, Muthiah
    Chiu, Nicholas
    Bhatt, Deepak L.
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2021, 68 : 97 - 98
  • [2] [Anonymous], 2021, Chronic Kidney Disease in the United States
  • [3] Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
    Bikbov, Boris
    Purcell, Carrie
    Levey, Andrew S.
    Smith, Mari
    Abdoli, Amir
    Abebe, Molla
    Adebayo, Oladimeji M.
    Afarideh, Mohsen
    Agarwal, Sanjay Kumar
    Agudelo-Botero, Marcela
    Ahmadian, Elham
    Al-Aly, Ziyad
    Alipour, Vahid
    Almasi-Hashiani, Amir
    Al-Raddadi, Rajaa M.
    Alvis-Guzman, Nelson
    Amini, Saeed
    Andrei, Tudorel
    Andrei, Catalina Liliana
    Andualem, Zewudu
    Anjomshoa, Mina
    Arabloo, Jalal
    Ashagre, Alebachew Fasil
    Asmelash, Daniel
    Ataro, Zerihun
    Atout, Maha Moh'd Wahbi
    Ayanore, Martin Amogre
    Badawi, Alaa
    Bakhtiari, Ahad
    Ballew, Shoshana H.
    Balouchi, Abbas
    Banach, Maciej
    Barquera, Simon
    Basu, Sanjay
    Bayih, Mulat Tirfie
    Bedi, Neeraj
    Bello, Aminu K.
    Bensenor, Isabela M.
    Bijani, Ali
    Boloor, Archith
    Borzi, Antonio M.
    Camera, Luis Alberto
    Carrero, Juan J.
    Carvalho, Felix
    Castro, Franz
    Catala-Lopez, Ferran
    Chang, Alex R.
    Chin, Ken Lee
    Chung, Sheng-Chia
    Cirillo, Massimo
    [J]. LANCET, 2020, 395 (10225) : 709 - 733
  • [4] Very Low-Calorie Ketogenic Diet: A Safe and Effective Tool for Weight Loss in Patients with Obesity and Mild Kidney Failure
    Bruci, Adriano
    Tuccinardi, Dario
    Tozzi, Rossella
    Balena, Angela
    Santucci, Silvia
    Frontani, Riccardo
    Mariani, Stefania
    Basciani, Sabrina
    Spera, Giovanni
    Gnessi, Lucio
    Lubrano, Carla
    Watanabe, Mikiko
    [J]. NUTRIENTS, 2020, 12 (02)
  • [5] The safety of pharmacologic treatment for pediatric obesity
    Chao, Ariana M.
    Wadden, Thomas A.
    Berkowitz, Robert I.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (04) : 379 - 385
  • [6] Venous Blood-Based Biomarkers in the China Health and Retirement Longitudinal Study: Rationale, Design, and Results From the 2015 Wave
    Chen, Xinxin
    Crimmins, Eileen
    Hu, Peifeng
    Kim, Jung Ki
    Meng, Qinqin
    Strauss, John
    Wang, Yafeng
    Zeng, Junxia
    Zhang, Yuan
    Zhao, Yaohui
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2019, 188 (11) : 1871 - 1877
  • [7] Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women
    Gambacciani, M
    Ciaponi, M
    Cappagli, B
    Piaggesi, L
    DeSimone, L
    Orlandi, R
    Genazzani, AR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) : 414 - 417
  • [8] Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis
    Hill, Nathan R.
    Fatoba, Samuel T.
    Oke, Jason L.
    Hirst, Jennifer A.
    O'Callaghan, Christopher A.
    Lasserson, Daniel S.
    Hobbs, F. D. Richard
    [J]. PLOS ONE, 2016, 11 (07):
  • [9] Body mass index and risk for end-stage renal disease
    Hsu, CY
    McCulloch, CE
    Iribarren, C
    Darbinian, J
    Go, AS
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 144 (01) : 21 - 28
  • [10] Associations of Glycated Albumin and HbA1c with Chronic Kidney Disease in US Adults
    Kim, Hyunju
    Tang, Olive
    Rebholz, Casey M.
    Grams, Morgan E.
    Coresh, Josef
    Christenson, Robert H.
    Selvin, Elizabeth
    [J]. JOURNAL OF APPLIED LABORATORY MEDICINE, 2022, 7 (04) : 842 - 853